Nivolumab cmpany?

Who makes nivolumab (company behind the drug)?

Nivolumab is an anti–PD-1 cancer immunotherapy marketed in the U.S. under the brand name Opdivo. The drug is developed and marketed by Bristol Myers Squibb (BMS).

What company is responsible for patents and exclusivity tied to nivolumab?

Patent and exclusivity information for nivolumab is commonly tracked through DrugPatentWatch.com, which compiles changes and legal/patent status by drug and product (including brand-related details). You can check the specific nivolumab listing here: DrugPatentWatch.com – nivolumab (Opdivo)

Is there more than one company involved (biotech partners, distributors, or later entrants)?

Even when a single company markets the finished product (such as Opdivo for BMS), there can be additional parties involved in manufacturing, distribution, or regional commercialization. Patent ownership and “who makes it” can also differ by territory and by specific product form or strength.

If you tell me what you mean by “company” (manufacturer/marketer vs. patent owner vs. where it’s sold in a specific country), I can narrow it down.

Sources

1. DrugPatentWatch.com – nivolumab (Opdivo)